← Leaderboards
David P Lillicrap
Medical College Of Wisconsin
$6,013,971
Attributed
$6,013,971
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $692.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,013,971 · 5
By mechanism
P01$5,083,294 · 4
U54$930,677 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Robert R Montgomery$28,575,312
- Raymond Quezon Migrino$1,515,059
- Sandra Haberichter$2,905,640
- David C Brousseau$8,506,713
- Qizhen Shi$6,437,223
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsGeneticInheritedPlasmaMouse ModelExperimental StudyBlood Coagulation DisordersRegulationHemorrhageFactor ViiiSiteModificationMediatingAreaGenotypeTraffickingBiologyBloodProteinsPrevalenceLocationCellsGenesPathology
Grant awards (17)
Investigation of factors regulating von Willebrand factor expression$337,603
P01 · FY2025 · HL · contact PI
Project 3: Contribution of Non-VWF Genomic Variants to Quantitative Von Willebrand Factor Pathologies$260,531
P01 · FY2023 · HL · contact PI
Project 3: Contribution of Non-VWF Genomic Variants to Quantitative Von Willebrand Factor Pathologies$234,588
P01 · FY2022 · HL · contact PI
Influence of the Host Microbiome on the Mechanism of FVIII Immunogenicity: Project 3$185,956
U54 · FY2022 · HL · contact PI
Project 3: Contribution of Non-VWF Genomic Variants to Quantitative Von Willebrand Factor Pathologies$261,556
P01 · FY2021 · HL · contact PI
Influence of the Host Microbiome on the Mechanism of FVIII Immunogenicity: Project 3$186,038
U54 · FY2021 · HL · contact PI
Project 3: Contribution of Non-VWF Genomic Variants to Quantitative Von Willebrand Factor Pathologies$264,421
P01 · FY2020 · HL · contact PI
Influence of the Host Microbiome on the Mechanism of FVIII Immunogenicity: Project 3$185,713
U54 · FY2020 · HL · contact PI
Project 3: Contribution of Non-VWF Genomic Variants to Quantitative Von Willebrand Factor Pathologies$188,330
P01 · FY2019 · HL · contact PI
Influence of the Host Microbiome on the Mechanism of FVIII Immunogenicity: Project 3$185,807
U54 · FY2019 · HL · contact PI
Influence of the Host Microbiome on the Mechanism of FVIII Immunogenicity: Project 3$187,163
U54 · FY2018 · HL · contact PI
Genetic Determinants of Quantitative Variants of von Willebrand Disease$343,976
P01 · FY2012 · HL · contact PI
Core A-ADMINISTRATIVE AND CLINICAL ACQUISITION CORE$678,996
P01 · FY2009 · HL · contact PI
Core A-ADMINISTRATIVE AND CLINICAL ACQUISITION CORE$692,252
P01 · FY2008 · HL · contact PI
Core A-ADMINISTRATIVE AND CLINICAL ACQUISITION CORE$618,654
P01 · FY2007 · HL · contact PI
Core A-ADMINISTRATIVE AND CLINICAL ACQUISITION CORE$584,336
P01 · FY2006 · HL · contact PI
Core A-ADMINISTRATIVE AND CLINICAL ACQUISITION CORE$618,051
P01 · FY2005 · HL